Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (71-80 of 266) with videos related to

Pageof 27
Sort By:
Blood|April 1, 1996
Desmopressin-induced thrombocytopenia in von Willebrand disease patients with the Arg611His mutation in the A1 domain of von Willebrand factorG Castaman, F Rodeghiero, J Eikenboom
Thrombosis and Haemostasis|April 1, 1997
Influence of cholesterol, triglycerides and fibrinogen on AT III, PC, HC-II and plasminogen measurementA Tosetto, E Gatto, F Rodeghiero
Blood Reviews|September 1, 1991
Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand diseaseF Rodeghiero, G Castaman, P M Mannucci
Lancet (London, England)|March 9, 1996
A bleeding disorder characterised by isolated deficiency of platelet microvesicle generationG Castaman, L Yu-Feng, F Rodeghiero
Journal of Thrombosis and Haemostasis : JTH|June 30, 2018
Thrombopoietin receptor agonists in hereditary thrombocytopeniasF Rodeghiero, A Pecci, C L Balduini
Thrombosis and Haemostasis|April 1, 1994
Angiodysplasia and von Willebrand's diseaseG Castaman, E Di Bona, F Rodeghiero
Thrombosis and Haemostasis|November 1, 1996
Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia AF Rodeghiero, G Castaman, P M Mannucci
Lancet (London, England)|November 2, 1985
Non-A, non-B hepatitis after factor VIII concentrate treated by heating and chloroformP M Mannucci, M Colombo, F Rodeghiero
Thrombosis and Haemostasis|August 26, 2000
Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V geneG Castaman, M Ruggeri, A Tosetto, et al.
Thrombosis and Haemostasis|December 29, 2000
The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and ArteriosclerosisA Tosetto, G Castaman, A Cappellari, et al.
Pageof 27

Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
Blood|April 1, 1996
Desmopressin-induced thrombocytopenia in von Willebrand disease patients with the Arg611His mutation in the A1 domain of von Willebrand factorG Castaman, F Rodeghiero, J Eikenboom
Thrombosis and Haemostasis|April 1, 1997
Influence of cholesterol, triglycerides and fibrinogen on AT III, PC, HC-II and plasminogen measurementA Tosetto, E Gatto, F Rodeghiero
Blood Reviews|September 1, 1991
Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand diseaseF Rodeghiero, G Castaman, P M Mannucci
Lancet (London, England)|March 9, 1996
A bleeding disorder characterised by isolated deficiency of platelet microvesicle generationG Castaman, L Yu-Feng, F Rodeghiero
Journal of Thrombosis and Haemostasis : JTH|June 30, 2018
Thrombopoietin receptor agonists in hereditary thrombocytopeniasF Rodeghiero, A Pecci, C L Balduini
Thrombosis and Haemostasis|April 1, 1994
Angiodysplasia and von Willebrand's diseaseG Castaman, E Di Bona, F Rodeghiero
Thrombosis and Haemostasis|November 1, 1996
Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia AF Rodeghiero, G Castaman, P M Mannucci
Lancet (London, England)|November 2, 1985
Non-A, non-B hepatitis after factor VIII concentrate treated by heating and chloroformP M Mannucci, M Colombo, F Rodeghiero
Thrombosis and Haemostasis|August 26, 2000
Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V geneG Castaman, M Ruggeri, A Tosetto, et al.
Thrombosis and Haemostasis|December 29, 2000
The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and ArteriosclerosisA Tosetto, G Castaman, A Cappellari, et al.
Pageof 27